160 related articles for article (PubMed ID: 37452325)
21. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
Hermunen K; Soveri LM; Boisen MK; Mustonen HK; Dehlendorff C; Haglund CH; Johansen JS; Osterlund P
Acta Oncol; 2020 Dec; 59(12):1416-1423. PubMed ID: 32790589
[TBL] [Abstract][Full Text] [Related]
22. Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer.
Shang A; Wang S; Yang Y; Li L; Zhao Z; Li D; Guo Y; Wang M
World J Surg Oncol; 2021 Mar; 19(1):84. PubMed ID: 33752702
[TBL] [Abstract][Full Text] [Related]
23. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
24. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
25. Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA.
Fenqi D; Yupeng L; Qiuju Z; Chao Y; Wenjie S; Tianyi X; Junnan G; Weinan X; Xiufeng J; Junge B; Chenyang J; Hua X; Yien L; Xuefeng B; Yanlong L
Front Oncol; 2021; 11():758509. PubMed ID: 35087748
[TBL] [Abstract][Full Text] [Related]
26. Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.
Wang L; Hirano Y; Ishii T; Kondo H; Hara K; Obara N; Yamaguchi S
World J Surg Oncol; 2020 Mar; 18(1):54. PubMed ID: 32160919
[TBL] [Abstract][Full Text] [Related]
27. Real-world Data for High-risk Stage II Colorectal Cancer - The Role of Tumor Side in the Adjuvant Setting.
Araujo CS; Venchiarutti Moniz CM; Bonadio RC; Watarai GY; Rojas J; Nogueira PVS; Martinez JK; Moraes PMG; Braghiroli MI; Sabbaga J; Hoff PM
Clin Colorectal Cancer; 2021 Jun; 20(2):e100-e108. PubMed ID: 33234431
[TBL] [Abstract][Full Text] [Related]
28. Identification of high-risk stage I colon and rectal cancer patients: a retrospective analysis of a large Japanese cohort.
Fukui Y; Hida K; Hoshino N; Nishizaki D; Okamura R; Yamauchi S; Sugihara K; Sakai Y;
Int J Colorectal Dis; 2022 Jun; 37(6):1403-1410. PubMed ID: 35588331
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
30. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
[TBL] [Abstract][Full Text] [Related]
31. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.
Ma L; Li W; Liu N; Ding Z; Cai J; Zhang Y
Updates Surg; 2022 Jun; 74(3):999-1009. PubMed ID: 35322387
[TBL] [Abstract][Full Text] [Related]
32. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
Li Z; Zhu H; Pang X; Mao Y; Yi X; Li C; Lei M; Cheng X; Liang L; Wu J; Ding Y; Yang J; Sun Y; Zhang T; You D; Liu Z
BMC Cancer; 2022 Sep; 22(1):962. PubMed ID: 36076189
[TBL] [Abstract][Full Text] [Related]
33. The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.
Chu-Yuan H; Jing P; Yi-Sheng W; He-Ping P; Hui Y; Chu-Xiong Z; Guo-Jian L; Guo-Qiang W
BMC Cancer; 2013 Apr; 13():177. PubMed ID: 23551939
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of increased preoperative red cell distribution width (RDW) and changes in RDW for colorectal cancer.
Lu X; Huang X; Xue M; Zhong Z; Wang R; Zhang W; Wang L; Qiao Y; Ling F; Zhang Q; Zhang Y
Cancer Med; 2023 Jun; 12(12):13361-13373. PubMed ID: 37143237
[TBL] [Abstract][Full Text] [Related]
35. Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer.
Ayude D; Rodríguez-Berrocal FJ; Ayude J; Blanco-Prieto S; Vázquez-Iglesias L; Vázquez-Cedeira M; Páez de la Cadena M
BMC Cancer; 2013 Nov; 13():543. PubMed ID: 24215576
[TBL] [Abstract][Full Text] [Related]
36. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
[TBL] [Abstract][Full Text] [Related]
38. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study.
Qaderi SM; Galjart B; Verhoef C; Slooter GD; Koopman M; Verhoeven RHA; de Wilt JHW; van Erning FN
Int J Colorectal Dis; 2021 Nov; 36(11):2399-2410. PubMed ID: 33813606
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification for predicting postoperative recurrence/metastasis of colorectal cancer by grade of venous invasion coupled with histological subtype.
Imai Y; Ichinose M
BMC Gastroenterol; 2022 Feb; 22(1):79. PubMed ID: 35197005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
